Page last updated: 2024-10-27

flecainide and Premature Birth

flecainide has been researched along with Premature Birth in 2 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Premature Birth: CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother's last menstrual period, or 245 days after FERTILIZATION).

Research Excerpts

ExcerptRelevanceReference
"High-dose flecainide and digoxin combination offers effective treatment strategy in fetuses with hydrops and tachyarrhythmia with favourable outcomes."4.12Favourable outcome for hydrops or cardiac failure associated with fetal tachyarrhythmia: a 20-year review. ( Beattie, RB; Tunca Sahin, G; Uzun, O, 2022)
"Standardized treatment of fetal tachyarrhythmia has not been established."2.90Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial. ( Hagiwara, A; Hamasaki, T; Horigome, H; Ikeda, T; Inamura, N; Kato, H; Katsuragi, S; Kawataki, M; Maeno, Y; Miyoshi, T; Nii, M; Sago, H; Sakaguchi, H; Shimizu, W; Shiraishi, I; Taketazu, M; Ueda, K; Yamamoto, H; Yasukochi, S; Yoda, H, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Tunca Sahin, G1
Beattie, RB1
Uzun, O1
Miyoshi, T1
Maeno, Y1
Hamasaki, T1
Inamura, N1
Yasukochi, S1
Kawataki, M1
Horigome, H1
Yoda, H1
Taketazu, M1
Nii, M1
Hagiwara, A1
Kato, H1
Shimizu, W1
Shiraishi, I1
Sakaguchi, H1
Ueda, K1
Katsuragi, S1
Yamamoto, H1
Sago, H1
Ikeda, T1

Trials

1 trial available for flecainide and Premature Birth

ArticleYear
Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial.
    Journal of the American College of Cardiology, 2019, 08-20, Volume: 74, Issue:7

    Topics: Administration, Oral; Adult; Anti-Arrhythmia Agents; Atrial Flutter; Cesarean Section; Digoxin; Fema

2019

Other Studies

1 other study available for flecainide and Premature Birth

ArticleYear
Favourable outcome for hydrops or cardiac failure associated with fetal tachyarrhythmia: a 20-year review.
    Cardiology in the young, 2022, Volume: 32, Issue:7

    Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cesarean Section; Digoxin; Female; Fetal Diseases; Fle

2022